NYSE$RMD
ResMed Inc · Q1 2024 earnings
Q1 2024 earnings · · Investor relations
Briefing
ResMed's first quarter of fiscal year 2024 results were announced, featuring revenue growth and increased adoption of software solutions.
ResMed Inc. reported a 16% increase in revenue to $1.1 billion for the first quarter of fiscal year 2024. The company saw growth across global sleep and respiratory care markets and increased adoption of outside hospital software solutions. Diluted earnings per share were reported at $1.49, with non-GAAP diluted earnings per share at $1.64.
- Revenue increased by 16% year-over-year, reaching $1.1 billion.
- Operating profit grew by 5%, with non-GAAP operating profit up by 10%.
- Diluted earnings per share were $1.49, and non-GAAP diluted earnings per share were $1.64.
- The company expects to resume its share repurchase program during the upcoming quarter.
Headline financials
Revenue & EPS history
ResMed · Revenue · Quarterly
$1.1B
Revenue by segment
ResMed · $963M total across 2 segments · Q1 2024
- Total Devices$565M—58.6%
- Total Masks and other$398M—41.4%
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2024
+0.1%
Avg return
Earnings day
+0.7%
Avg return
5 days after
+1.2%
Avg return
30 days after
49%
33 / 67 earnings
Positive
+18.7%
Q3 2024
Best reaction
-19.3%
Q2 2019
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q3 2026 | -2.9% | -2.0% | -10.8% | |
| Q2 2026 | -1.5% | +2.1% | -0.5% | |
| Q1 2026 | -1.5% | -2.8% | +1.4% | |
| Q3 2025 | +10.1% | +10.9% | +13.2% | |
| Q2 2025 | -8.3% | -5.8% | -9.4% | |
| Q1 2025 | +7.9% | +2.9% | +2.7% | |
| Q4 2024 | +4.9% | +2.6% | +14.9% | |
| Q3 2024 | +18.7% | +16.4% | +16.0% | |
| Q2 2024 | +6.5% | +9.3% | +5.2% | |
| Q1 2024 | -4.2% | +0.5% | +9.5% | |
| Q4 2023 | -19.3% | -19.3% | -28.3% | |
| Q3 2023 | +7.6% | +5.4% | -3.8% | |
| Q2 2023 | -2.8% | -1.2% | -8.5% | |
| Q1 2023 | -6.5% | -5.6% | -1.7% | |
| Q4 2022 | -1.5% | -3.1% | -3.1% | |
| Q3 2022 | -6.9% | -8.5% | -3.0% | |
| Q2 2022 | -6.5% | +0.5% | +6.2% | |
| Q1 2022 | -1.9% | -2.1% | -6.3% | |
| Q4 2021 | +0.5% | +0.7% | +8.3% | |
| Q3 2021 | -10.6% | -8.6% | -2.0% | |
| Q2 2021 | -5.8% | -3.5% | -9.9% | |
| Q1 2021 | +6.2% | +12.1% | +16.0% | |
| Q4 2020 | -13.4% | -13.6% | -14.4% | |
| Q3 2020 | +1.8% | +2.0% | +2.9% | |
| Q2 2020 | -4.1% | +0.6% | -4.1% | |
| Q1 2020 | +13.8% | +15.7% | +14.6% | |
| Q4 2019 | +1.1% | +3.8% | +5.4% | |
| Q3 2019 | +7.9% | +7.6% | +9.3% | |
| Q2 2019 | -19.3% | -21.5% | -13.6% | |
| Q1 2019 | +6.2% | +7.3% | +5.7% | |
| Q4 2018 | -2.1% | +0.7% | +4.1% | |
| Q3 2018 | -2.1% | -1.4% | +6.9% | |
| Q2 2018 | +13.2% | +15.9% | +5.1% | |
| Q1 2018 | +7.7% | +7.4% | +8.6% | |
| Q4 2017 | -6.0% | -2.6% | +0.6% | |
| Q3 2017 | -5.2% | -2.7% | -2.3% | |
| Q2 2017 | +9.5% | +7.1% | +13.7% | |
| Q1 2017 | -5.0% | -5.3% | -8.7% | |
| Q4 2016 | +5.8% | +6.5% | +6.0% | |
| Q3 2016 | -7.4% | — | — | |
| Q2 2016 | +7.1% | — | — | |
| Q1 2016 | +0.1% | — | — | |
| Q4 2015 | +3.6% | — | — | |
| Q3 2015 | -10.3% | — | — | |
| Q2 2015 | +8.6% | — | — | |
| Q1 2015 | +9.5% | — | — | |
| Q4 2014 | -4.1% | — | — | |
| Q3 2014 | -0.4% | — | — | |
| Q2 2014 | -5.7% | — | — | |
| Q1 2014 | -13.2% | — | — | |
| Q4 2013 | +0.5% | — | — | |
| Q3 2013 | +0.9% | — | — | |
| Q2 2013 | +7.0% | — | — | |
| Q1 2013 | -4.7% | — | — | |
| Q4 2012 | +12.8% | — | — | |
| Q3 2012 | +7.6% | — | — | |
| Q2 2012 | +9.7% | — | — | |
| Q1 2012 | -12.0% | — | — | |
| Q4 2009 | -5.4% | — | — | |
| Q4 2011 | -5.4% | — | — | |
| Q3 2011 | -0.9% | — | — | |
| Q3 2010 | -0.9% | — | — | |
| Q2 2010 | +2.2% | — | — | |
| Q2 2011 | +2.2% | — | — | |
| Q1 2010 | +3.6% | — | — | |
| Q1 2011 | +3.6% | — | — | |
| Q4 2010 | +3.6% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro